LE Magazine July 2001
Page 4 of 4
Barbagallo CM et al.: Lipoprotein profile and high-density lipoproteins: subfractions distribution in centenarians. Gerontology 1998; 44(2):106-10.
Biagi PL et al.: Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. Biochim Biophys Acta. 1991; 1083(2):187-92.
Birch EE et al.: A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000; 42(3):174-81.
Bolton-Smith C et al.: Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet. Eur J Clin Nutr. 1997; 51(9):619-24.
Borkman M, Storlien LH et al.: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med. 1993; 328(4):238-44.
Christensen NJ et al.: Resting venous plasma adrenalin in 70-year-old men correlated positively to survival in a population study: the significance of the physical working capacity. J Intern Med. 1994; 235(3):229-32.
Daviglus ML et al.: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997; 336(15):1046-53.
de Urquiza AM et al.: Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 2000; 290(5499):2140-4.
Engler MM: Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids. 1993; 49(4):809-14.
Engler MM et al.: Dietary gamma-linolenic acid lowers blood pressure and alters aortic reactivity and cholesterol metabolism in hypertension. J Hypertens. 1992; 10(10):1197-204.
Engler MM et al.: Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc Soc Exp Biol Med. 1998; 218(3):234-7.
Engler MM et al.: Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc Soc Exp Biol Med. 1999; 221(1):32-8.
Fardella CE et al.: Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000; 85(5):1863-7.
Forman BM et al.: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A. 1997; 94(9):4312-7.
Fragoso YD et al.: The effect of gammalinolenic acid on the subfractions of plasma high density lipoprotein of the rabbit. Biochem Pharmacol. 1992; 44(6):1085-90.
Greiner RS et al.: Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-based and spatial learning tasks. Lipids. 1999; 34 Suppl:S239-43.
Guivernau M et al.: Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids. 1994; 51(5):311-6.
Hamazaki T, Sawazaki S et al.: The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest. 1996; 97(4):1129-33.
Hamazaki T, Sawazaki S et al.: Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress. Lipids. 1999; 34 Suppl:S33-7.
Horrobin DF: Loss of delta-6-desaturase activity as a key factor in aging. Med Hypotheses. 1981; 7(9):1211-20.
Horrobin DF: The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. Rev Pure Appl Pharmacol Sci. 1983; 4(4):339-83.
Horrobin DF.: Fatty acid metabolism in health and disease: the role of delta-6-desaturase. Am J Clin Nutr. 1993; 57(5 Suppl):732S-736S.
Horrocks LA and Yeo YK: Docosahexaenoic acid-enriched foods: production and effects on blood lipids. Lipids. 1999; 34 Suppl:S313.
Horrocks LA, Yeo YK: Health benefits of docosahexaenoic acid (DHA) Pharmacol Res. 1999; 40(3):211-25.
Khalilov EM et al.: Omega-6 and omega-3 polyunsaturated fatty acids in experimental atherosclerosis regression. EFA & Eicosanoids 1997, Edinburgh.
Kimura S etal.: Dietary docosahexaenoic acid (22:6n-3) prevents the development of hypertension in SHRSP. Clin Exp Pharmacol Physiol. 1995; 22 Suppl 1:S308-9.
Kyle DJ et al.: Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia. Lipids. 1999; 34 Suppl:S245.
Lim SY and Suzuki H: Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice. J Nutr. 2000; 130(6):1629-32.
Lim SY and Suzuki H: Changes in Maze Behavior of Mice Occur after Sufficient Accumulation of Docosahexaenoic Acid in Brain. J Nutr. 2001; 131(2):319-324.
Mills DE et al.: Gamma linolenic acid attenuates cardiovascular responses to stress in borderline hypertensive rats. Lipids. 1985; 20(9):573-7.
Mills DE et al.: Effects of essential fatty acid administration on cardiovascular responses to stress in the rat. Lipids. 1986; 21(2):139-42.
Mills DE et al.: Dietary fatty acid supplementation alters stress reactivity and performance in man. J Hum Hypertens. 1989; 3(2):111-6.
Mills DE and Ward Ron P: Dietary n-6 and n-3 Fatty Acids and Stress-induced Hypertension. Pathophysiology and Roles in Clinical Medicine 1990; pp 145-156.
Minami M et al.: Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav. 1997; 58(4):1123-9.
Mori TA et al.: Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension. 1999; 34(2):253-60.
Pan DA et al.: Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest. 1995; 96(6):2802-8.
Prisco D et al.: Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Prostaglandins Leukot Essent Fatty Acids. 2000; 62(2):129-34.
Sawazaki S et al.: The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double-blind placebo-controlled study. J Nutr Sci Vitaminol (Tokyo). 1999; 45(5):655-65.
Singer P et al.: Effects of dietary oleic, linoleic and alpha-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension. J Hum Hypertens. 1990; 4(3):227-33.
Stark KD et al.: Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. Am J Clin Nutr. 2000; 72(2):389-94.
Storlien LH et al.: Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol. 1986; 251(5 Pt 1):E576-83.
Storlien LH et al.: Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science. 1987; 237(4817):885-8.
Storlien LH et al.: Dietary fats and insulin action. Diabetologia 1996; 39(6):621-31.
Terano T et al.: Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids. 1999; 34 Suppl:S345-6.
van Jaarsveld PJ et al.: The influence of different ratios and dosages of an w6:w3 fatty acid supplement on the lipoprotein cholesterol and fatty acid profile in nonhuman primates on a Western atherogenic diet. Nutrition Research 1997; 17 (11/12);1733-1747.
Venter CP et al.: Effects of essential fatty acids on mild to moderate essential hypertension. Prostaglandins Leukot Essent Fatty Acids. 1988; 33(1):49-51.
Vessby B et al.: Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia. 1994; 37(10):1044-50.
Wahli W et al.: Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. Adv Exp Med Biol. 1999; 447:199-209.
Weber KT: Aldosterone and spironolactone in heart failure. N Engl J Med. 1999; 341(10):753-5.
Back to the Magazine Forum